| GC38043-100mg |
|
2165322-94-9 |
|
0 |
C17H16BrF4NO2 |
|
|
|
| GC38043-50mg |
|
2165322-94-9 |
|
0 |
C17H16BrF4NO2 |
|
|
|
| GC38043-25mg |
|
2165322-94-9 |
|
0 |
C17H16BrF4NO2 |
|
|
|
| GC38043-10mg |
|
2165322-94-9 |
|
0 |
C17H16BrF4NO2 |
|
|
|
| GC38043-5mg |
|
2165322-94-9 |
|
0 |
C17H16BrF4NO2 |
|
|
|
| GC38043-1mg |
|
2165322-94-9 |
|
0 |
C17H16BrF4NO2 |
|
|
|
| GC38042-10mg |
|
— |
α-Factor Mating Pheromone, yeast (TFA)
|
0 |
C84H115N20F3O19S |
|
|
|
| GC38042-5mg |
|
— |
α-Factor Mating Pheromone, yeast (TFA)
|
0 |
C84H115N20F3O19S |
|
|
|
| GC38042-1mg |
|
— |
α-Factor Mating Pheromone, yeast (TFA)
|
0 |
C84H115N20F3O19S |
|
|
|
| GC38041-500mg |
|
1353012-00-6 |
|
0 |
C17H20F5N3O6 |
|
|
|
| GC38041-100mg |
|
1353012-00-6 |
|
0 |
C17H20F5N3O6 |
|
|
|
| GC38040-500mg |
|
159857-90-6 |
Cbz-Phe-(Alloc)Lys-PAB-PNP
|
0 |
C41H43N5O11 |
|
|
|
| GC38040-100mg |
|
159857-90-6 |
Cbz-Phe-(Alloc)Lys-PAB-PNP
|
0 |
C41H43N5O11 |
|
|
|
| GC38039-10mg |
|
1639220-15-7 |
Sigma-1 receptor antagonist 2
|
0 |
C20H26ClN3O2 |
|
|
|
| GC38039-5mg |
|
1639220-15-7 |
Sigma-1 receptor antagonist 2
|
0 |
C20H26ClN3O2 |
|
|
|
| GC38039-1mg |
|
1639220-15-7 |
Sigma-1 receptor antagonist 2
|
0 |
C20H26ClN3O2 |
|
|
|
| GC38039-10mM (in 1mL DMSO) |
|
1639220-15-7 |
Sigma-1 receptor antagonist 2
|
0 |
C20H26ClN3O2 |
|
|
|
| GC38038-10mg |
|
1639220-19-1 |
Sigma-1 receptor antagonist 1
|
0 |
C19H23Cl2N3O |
|
|
|
| GC38038-5mg |
|
1639220-19-1 |
Sigma-1 receptor antagonist 1
|
0 |
C19H23Cl2N3O |
|
|
|
| GC38038-1mg |
|
1639220-19-1 |
Sigma-1 receptor antagonist 1
|
0 |
C19H23Cl2N3O |
|
|
|
